Bone health in type 1 diabetes: Focus on evaluation and treatment in clinical practice

Journal of Endocrinological Investigation

Volumn 38, Issue 9, 2015, Pages 941-950

  Zhukouskaya, V V ^a,b,c   Eller Vainicher, C ^a,b   Shepelkevich, A P ^d   Dydyshko, Y ^d   Cairoli, E ^a,b   Chiodini, I ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

Bone mineral density; Chronic diabetic complications; Fracture risk; Pathophysiology; Type 1 diabetes

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; GLUCOSE; INSULIN; PARATHYROID HORMONE[1-34]; ROMOSOZUMAB; SOMATOMEDIN C; VITAMIN D; GLUCOSE BLOOD LEVEL;

ASYMPTOMATIC DISEASE; BODY MASS; BONE DENSITY; BONE DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FUNCTION; NONHUMAN; REVIEW; RISK FACTOR; SECONDARY OSTEOPOROSIS; SPINE FRACTURE; SPINE RADIOGRAPHY; THORAX RADIOGRAPHY; BLOOD; BONE; BONE REMODELING; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLISM; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD GLUCOSE; BONE AND BONES; BONE DENSITY; BONE REMODELING; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; OSTEOPOROSIS; VITAMIN D;

EID: 84940035191     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0284-9     Document Type: Review

References (70)

1. Van Belle TL, Coppieters KT, Von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91:79-118
2. Guariguata L (2011) Estimating the worldwide burden of type 1 diabetes. Diabetes Voice 56(2):6-8
3. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 18:427-444
4. Eller-Vainicher C, Zhukouskaya VV, Tolkachev YV, Koritko SS, Cairoli E, Grossi E, Beck-Peccoz P, Chiodini I, Shepelkevich AP (2011) Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis. Diabetes Care 34:2186-2191
5. Bechtold S, Dirlenbach I, Raile K, Noelle V, Bonfig W, Schwarz PH (2006) Early manifestation of type 1 diabetes in children is a risk factor for changed bone geometry: data using peripheral quantitative computed tomography. Pediatrics 118:e627-e634
6. Saha MT, Sievanen H, Salo MK, Tulokas S, Saha HH (2009) Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int 20:1401-1406
7. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, Wang X (2009) Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res 24:1618-1627
8. Nyman JS, Even JL, Jo CH, Herbert EG, Murry MR, Cockrell GE, Wahl EC, Bunn RC, Lumpkin CK, Fowlkes JL, Thrailkill KM (2011) Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone 48:733-740
9. Erdal N, Gurgul S, Demirel C, Yildiz A (2012) The effect of insulin therapy on biomechanical deterioration of bone in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats. Diab Res Clin Pract 97(3):461-467
10. Bechtold S, Putzker S, Bonfig W, Fuchs O, Dirlenbach I, Schwarz HP (2007) Bone size normalizes with age in children and adolescents with type 1 diabetes. Diabetes Care 30:2046-2050
11. Roggen I, Gies I, Vanbesien J, Louis O, De Schepper J (2013) Trabecular bone mineral density and bone geometry of the distal radius at the completion of pubertal growth in childhood type 1 diabetes. Horm Res Pediatr 79:68-74
12. Armas LAG, Akhter MP, Drincic A, Recker RR (2012) Trabecular bone histomorphometry in humans with type 1 diabetes. Bone 50:91-96
13. Danielson KK, Elliott ME, LeCaire T, Binkley N, Palta M (2009) Poor Glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int 20(6):923-933
14. Neumann T, Samann A, Lodes S, Kastner B, Franke S, Kiehntopf M, Hemmelmannt C, Lehmannt L, Muller UA, Hein G, Wolf G (2011) Glycemic control is positively associated with prevalent fractures but not with bone mineral density in patients with type 1 diabetes. Diabet Med 28:872-875
15. Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, Shepelkevich AP, Zhurava IV, Korolenko GG, Salko OB, Cairoli E, Beck-Peccoz P, Chiodini I (2013) Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care 36:1635-1640
16. Retzepi M, Donos N (2010) The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res 21:673-681
17. Starup-Linde J (2013) Diabetes, biochemical markers of bone turnover, diabetes control and bone. Front Endocrinol 4(21):1-17
18. McCabe LR, Zhang J, Raehtz S (2011) Understanding the skeletal pathology of type 1 and 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr 21(2):187-206
19. Hie M, Iitsuka N, Otsuka T, Tsukamoto I (2011) Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28(3):455-462
20. Zhao YF, Zeng DL, Xia LG, Zhang SM, Xu LY, Jiang XQ, Zhang FQ (2013) Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. Int J Mol Med 31:614-620
21. Portal-Núñez S, Lozano D, Fernández de Castro L, de Gortázar AR, Nogués X, Esbrit P (2010) Alterations of the Wnt/b-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice. FEBS Lett 584:3095-3100
22. Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411-424
23. Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043:710-717
24. Fowlkes JL, Bunn RC, Thrailkill KM (2011) Contribution of insulin/insulin-like growth factor-1 axis to diabetic osteopathy. J Diabetes Metab S1(003):1-7
25. Hamada Y, Kitazawa S, Kitazawa R, Fujii H, Kasuga M, Fukagawa M (2007) Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Bone 40:1408-1414
26. Coe LM, Irwin R, Lippner D, McCabe LR (2011) The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol 226(2):477-483
27. Motyl KJ, Botolin S, Irwin R, Appledorn DM, Kadakia T, Amalfitano A, Schwartz RC, McCabe LR (2009) Bone inflammation and altered gene expression with type I diabetes early onse. J Cell Physiol 218:575-583
28. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 31:1729-1735
29. Leger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Levy Marchal C, Tubiana-Rufi N, Sebag G, Czernichow P (2006) Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type i levels, and high insulin requirement. J Clin Endocrinol Metab 91(10):3947-3953
30. Moyer-Mileur LJ, Slater H, Jordan KC, Murray MA (2008) IGF-1 and IGF-binding proteins and bone mass, geometry and strength: relation to metabolic control in adolescent girls with type 1 diabetes. J Bone Miner Res 23:1884-1891
31. Van Sickle BJ, Simmons J, Hall R, Raines M, Ness K, Spagnoli A (2009) Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus. Cytokine 48(3):290-294
32. Thrailkill KM, Fowlkes JL (2013) The role of vitamin D in the metabolic homeostasis of diabetic bone. Clin Rev Bone Miner Metab 11:28-37
33. Salvatoni A, Mancassola G, Biasoli R, Cardani R, Salvatore S, Broggini M, Nespoli L (2004) Bone mineral density in diabetic children and adolescents: a follow-up study. Bone 34:900-904
34. Pascual J, Argente J, Lopez MB, Munoz M, Martinez G, Vazquez MA, Jodar E, Perez-Cano R, Hawkins F (1998) Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int 62:31-35
35. Brandao FR, Vicente EJ, Daltro CH, Sacramento M, Moreira A, Adan L (2007) Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 78:334-339
36. Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T (2003) Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 26:2365-2369
37. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR (1998) Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413-419
38. Miazgowski T, Pynka S, Noworyta-Zietara M, Krzyzanowska-Swiniarska B, Pikul R (2007) Bone mineral density and hip structural analysis in type 1 diabetic men. Eur J Endocrinol 156:123-127
39. Joshi A, Varthakavi P, Chadha M, Bhagwat N (2013) A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. doi: 10.1155/2013/397814 Epub 2013 Mar 31
40. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A (2002) The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58(6):266-272
41. Heilman K, Zilmer M, Zilmer K, Tillmann V (2009) Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels. J Bone Miner Metab 27(5):598-604
42. Camurdan MO, Cinaz P, Bideci A, Demire F (2007) Role of hemoglobin A1c, duration and puberty on bone mineral density in diabetic children. Pediatrics Int 49:645-651
43. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD (1996) Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin dependent diabetes mellitus. Calcif Tissue Int 58:316-319
44. Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia-Cervigon AG (2000) Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 11:455-459
45. Rozadilla A, Nolla JM, Montana E, Fiter J, Gomez-Vaquero C, Soler J, Roig-Escofet D (2000) Bone mineral density in patients with type 1 diabetes mellitus. Joint Bone Spine 67:215-218
46. Wilkin TJ (2013) Is Autoimmunity or insulin resistance the primary driver of type 1 diabetes? Curr Diabetes Rep 13:651-656
47. Jamal SA, Swan VJD, Brown JP, Hanley DA, Prior JC, Papaioannou A, Langsetmo L, Josse RG (2010) Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis 55:291-299
48. Morelli V, Eller-Vainicher C, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res 26:1816-1821
49. Vestergaad P, Rejnmark L, Mosekilde L (2009) Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 84:45-55
50. Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23(12):2735-2748
51. Montagnani A, Gonelli S (2013) Antidiabetic therapy effects on bone metabolism and fracture risk. Diabetes Obes Metab 15:784-791
52. Hegazy SK (2015) Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women. J Bone Miner Metab 33(2):207-212
53. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington, DC
54. Chrysant SG, Chrysant GS (2014) Controversy regarding the association of high calcium intake and increased risk for cardiovascular disease. J Clin Hypertens 16(8):545-550
55. Wang X, Chen H, Ouyang Y, Liu J, Zhao G, Bao W, Yan M (2014) Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med 12(158):1-10
56. Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29(4):305-313
57. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96(7):1-20
58. Maggio ABR, Rizzoli RR, Marchand LM, Ferrari S, Beghetti M, Farpour-Lambert J (2012) Physical activity increases bone minreal density in children with type 1 diabetes. Med Sci Sports Exerc 44(7):1206-1211
59. Keegan THM, Schwartz AV, Bauer DC, Sellmeyer DE, Kelsey JL (2004) Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women. Diabetes Care 27:1547-1553
60. Vestergaad P, Rejnmark L, Mosekilde L (2011) Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 88:209-214
61. Zaheer S, LeBoff M, Lewiecki EM (2015) Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol 11(3):461-470. doi: 10.1517/17425255.2015.1000860
62. Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I (2015) Perspectives on osteoporosis therapies. J Endocrinol Investig. doi: 10.1007/s40618-014-0236-9
63. Motyl KJ, McCauley LK, McCabe LR (2012) Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival. J Cell Physiol 227(4):1326-1334
64. Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabro A, Cataldo D, Stolakis K, Dotta F, Nuti R (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 97(5):1737-1744
65. McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370(5):412-420
66. Hamann C, Rauner M, Hohna Y, Bernhardt R, Mettelsiefen Y, Goettsch C, Gunther KP, Stolina M, Han CY, Asuncion FJ, Ominsky MS, Hofbauer LC (2013) Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. J Bone Miner Res 28(3):627-638
67. Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14:302-312
68. Leslie WD, Aubry-Rozier B, Lamy O, Hans D (2013) TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab 98(2):602-609
69. Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I (2012) Bone quality, as measured by trabecular bone score (TBS), in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27(10):2223-2230
70. Zaia A (2015) Fractal lacunarity of trabecular bone and magnetic resonance imaging: new perspectives for osteoporotic fracture risk assessment. World J Orthop 6(2):221-235